Obstructive Sleep Apnea is a major driver of lost workplace productivity and is associated with comorbidities like high blood pressure and obesity. The only current treatment is the CPAP machine that forces air into the lungs; this is so uncomfortable that use compliance stands at 20% of prescriptions. Apnimed has discovered a combination of 2 approved drugs used in combination to prevent airway collapse and prevent hypoxic events during sleep. The company has completed phase 2 trials.